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The CCR4–NOT deadenylase complex safeguards
thymic positive selection by down-regulating
aberrant pro-apoptotic gene expression
Taku Ito-Kureha1, Takahisa Miyao2, Saori Nishijima1, Toru Suzuki 3, Shin-ichi Koizumi4,
Alejandro Villar-Briones5, Akinori Takahashi1, Nobuko Akiyama3, Masahiro Morita 6, Isao Naguro 7,
Hiroki Ishikawa4, Hidenori Ichijo 7, Taishin Akiyama 2✉ & Tadashi Yamamoto 1,3✉
A repertoire of T cells with diverse antigen receptors is selected in the thymus. However,
detailed mechanisms underlying this thymic positive selection are not clear. Here we show
that the CCR4-NOT complex limits expression of specific genes through deadenylation of
mRNA poly(A) tails, enabling positive selection. Specifically, the CCR4-NOT complex is up-
regulated in thymocytes before initiation of positive selection, where in turn, it inhibits up-
regulation of pro-apoptotic Bbc3 and Dab2ip. Elimination of the CCR4-NOT complex permits
up-regulation of Bbc3 during a later stage of positive selection, inducing thymocyte apoptosis.
In addition, CCR4-NOT elimination up-regulates Dab2ip at an early stage of positive selec-
tion. Thus, CCR4-NOT might control thymocyte survival during two-distinct stages of
positive selection by suppressing expression levels of pro-apoptotic molecules. Taken
together, we propose a link between CCR4-NOT-mediated mRNA decay and T cell selection
in the thymus.
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Many T cells, which are necessary for acquired immuneresponses, are generated in the thymus. In the thymiccortex, progenitor cells originally derived from hema-
topoietic stem cells, differentiate into immature thymocytes
expressing both CD4 and CD8 co-receptors (DP thymocytes)1.
DP thymocytes undergo a life-or-death selection event controlled
primarily by signals from T cell antigen receptors (TCR) and
peptide–major histocompatibility complex (pMHC) conjugates2.
During this selection event, DP thymocytes undergo a positive
selection process that is crucial for the generation of a self-MHC-
restricted TCR repertoire to defend against practically all patho-
gens. Positive selection commits DP thymocytes to either the
CD4 or the CD8 lineage, depending on the type of co-receptor
signaling. Consequently, CD4 and CD8 single-positive (SP)
T cells emigrate to peripheral tissues after another round of
selection to eliminate self-reactive T cells in the thymic medulla.
Once TCRs have been stimulated by the peptide–MHC com-
plex during positive selection, various signaling cascades,
including mitogen-activated protein kinase (MAPK), NF-κB
activation, and calcium mobilization are activated2–5. These dif-
ferentiation signals are transduced to direct the final outcome of
thymocyte differentiation, proliferation, and survival, or pro-
grammed cell death.
Death of thymocytes is critical for T cell development and
repertoire formation6. Several studies have suggested that the
mitochondrial apoptotic pathway is required for thymocyte
deletion7–9. BH3-only protein family member, BIM, induces
TCR-mediated apoptosis10,11. In addition, Bbc3 (also called the
p53-up-regulated modulator of apoptosis, PUMA) cooperates
with BIM in this process12. Mechanistically, BIM and Bbc3
antagonize pro-survival Bcl2 family proteins (i.e., Bcl-2, Bcl-xL,
Mcl-1) binding to pro-apoptotic proteins, Bax and Bak, thereby
releasing them to activate the apoptotic pathway. Several MAPKs,
extracellular signal-related kinases (Erk), c-Jun N-terminal kina-
ses (Jnk), and p38-MAPK (p38) are also activated by TCR sig-
naling. Because p38 and Jnk mediate death signaling13–15, tight
regulation of kinases during TCR-induced signaling is required
for thymocyte survival.
Recent evidence demonstrates that post-transcriptional reg-
ulation influences T cell differentiation and function. Roquins
and Regnase 1, which are involved in T cell differentiation or
development of autoimmune diseases16–18, bind to the 3′-
untranslated regions (UTRs) of target mRNAs and drive mRNA
degradation. miRNAs also participate in post-transcriptional
regulation of mRNAs during T cell development or TCR sig-
naling. For example, severe block of CD8SP thymocyte develop-
ment, but not CD4SP, is observed upon dcr-1 deletion in the
thymus19. Also, miR-181a is an intrinsic modulator of T cell
antigen during T cell development20.
Deadenylation of mRNA poly(A) tails is the rate-limiting step
in mRNA translation because it determines steady-state mRNA
levels and/or translational efficiency21,22. In eukaryotes, mRNA
deadenylation is primarily catalyzed by the CCR4-NOT
complex23,24. CCR4–NOT promotes post-transcriptional silen-
cing through the association of miRNAs or various RNA-binding
proteins (RBPs)25–27. The CCR4–NOT complex is comprised of
subunits with deadenylase activity (CNOT6 or CNOT6L and
CNOT7 or CNOT8) and regulatory NOT modules (CNOT1,
CNOT2, CNOT3, CNOT9, CNOT10, and CNOT11)23,24.
CNOT1 serves as a scaffold for the whole complex, as evidenced
by the observation that CNOT1 depletion deteriorates the com-
plex28. Accumulating evidence suggests that the CCR4–NOT
complex controls degradation/translation of mRNAs in a context-
dependent manner. Previous studies revealed that CNOT7 defi-
ciency results in defects in spermatogenesis and bone
formation29,30. CNOT3 hetero-deficient mice are resistant to
high-fat, diet-induced obesity, but are prone to develop heart
failure and osteoporosis31–33. Another recent study demonstrated
that B cell-specific depletion of CNOT3 attenuates early B cell
development at a pre-B cell stage34. These studies imply reg-
ulatory roles of poly(A) tail shortening by the CCR4–NOT
complex in various cell types, although its significance in T cell
differentiation and selection had not been examined.
Here, we show that CNOT3 reduction, which decreases
deadenylase activity of the CCR4–NOT complex toward target
mRNAs, impairs positive selection of thymocytes. Deletion of
CNOT3 provokes inappropriate apoptosis during the process of
positive selection by increasing the expression of pro-apoptotic
molecules. Consequently, CCR4–NOT controls T cell repertoire
formation by fine-tuning cell survival and death in the thymus.
Results
CNOT3 is up-regulated in DP thymocytes, promoting their
development. Many subunits of the CCR4–NOT complex are
expressed in the thymus35, suggesting the involvement of the com-
plex in thymic T cell development. Therefore, we examined subunit
expression levels in thymocyte populations separated according to
their expression of CD4 and CD8. Quantitative PCR (qPCR) analysis
showed that expression of Cnot1, Cnot2, Cnot3, Cnot6, Cnot7, and
Cnot8 was up-regulated in CD4+CD8+ (DP) thymocytes, compared
to CD4–CD8– (DN) thymocytes (Fig. 1a). Western blot analysis
confirmed that CNOT1, CNOT2, CNOT3, and CNOT6 proteins
were transiently up-regulated in DP thymocytes (Fig. 1b), whereas
CNOT6L, CNOT7, CNOT8, and CNOT9 proteins were expressed
continuously throughout their differentiation.
Since CNOT3 is essential for the integrity of the CCR4–NOT
complex36 and was up-regulated in DP thymocytes at both mRNA
and protein levels (Fig. 1a, b), we analyzed Cnot3+/− mice32 to
address functions of the CCR4–NOT complex in thymocyte
development and selection. Numbers of total thymocytes and DP
thymocytes were not significantly changed in Cnot3+/− thymus
(Fig. 1c). However, hetero-deficiency of the Cnot3 gene caused a
significant reduction in numbers and percentages of CD4+CD8–
(CD4SP) and CD8+CD4– (CD8SP) thymocytes (Fig. 1c and
Supplementary Fig. 1a). These data suggested the participation of
the CCR4–NOT complex in the development of SP thymocytes.
Moreover, it appeared that a small change in CNOT3 expression
might affect SP thymocyte generation.
Because Cnot3-null mice die during embryonic development,
mice lacking CNOT3 only in T cells were generated using a Cre
transgene under control of the cd4 enhancer/promoter/silencer
(Cnot3f/f Cd4-Cre mice). A PCR-based assay showed that the
Cnot3 allele was efficiently deleted in DP and SP thymocytes of
Cnot3f/f Cd4-Cre mice (Supplementary Fig. 1b). Expression of
CNOT3 protein was also efficiently suppressed in DP thymocytes
(Fig. 1d). Notably, the absence of CNOT3 caused a severe
reduction in expression of other CNOT proteins, including
CNOT1, CNOT2, CNOT7, CNOT8, CNOT9, and CNOT10
(Fig. 1d), suggesting that CNOT3 deletion suppressed the
formation of the CCR4–NOT complex in DP thymocytes. We
investigated thymocyte development in Cnot3f/f Cd4-Cre mice
using a flow cytometer. Whereas changes in numbers of total
thymocytes and DP thymocytes were not significant in Cnot3f/f
Cd4-Cre mice (Fig. 1e), numbers and percentages of CD4SP and
CD8SP thymocytes were significantly decreased in Cnot3f/f Cd4-
Cre mice (Fig. 1e), consistent with results in Cnot3+/– mice
(Fig. 1c). A cell-intrinsic requirement of CNOT3 for development
of CD4SP and CD8SP was further confirmed with a mixed
chimera experiment. Chimeric mice simultaneously receiving
Cnot3f/f Cd4-Cre (CD45.2+) and wildtype (CD45.1+) bone
marrow cells showed a lower proportion of CD4SP and CD8SP
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thymocytes in only the CD45.2+ cell fraction (Supplementary
Fig. 1c). These results demonstrated that in thymocytes the
CCR4–NOT complex promotes the generation of thymic CD4SP
and CD8SP T cells in cell-intrinsic fashion.
CNOT3 regulates positive selection of DP thymocytes. We next
determined which thymocyte differentiation stage was impaired
in Cnot3f/f Cd4-Cre mice. During thymic T cell development,
thymocytes receive TCR signaling for repertoire formation. Thus,
thymocytes are classified by differences in expression levels of cell
surface CD3 and CD69, which are up-regulated by TCR
engagement. qPCR analysis showed that Cnot1, Cnot2, Cnot3,
Cnot6, Cnot7, and Cnot8 were up-regulated during differentiation
of DN to CD3intCD69lo thymocytes, indicating that they were up-
regulated prior to TCR engagement in DP thymocytes (Fig. 2a).
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Fig. 1 CNOT3 promotes generation of thymic CD4SP and CD8SP in a cell-intrinsic manner. a qPCR analysis of subunits of the CCR4–NOT complex in
thymocyte subsets sorted by flow cytometry. Results are presented relative to Gapdh expression. Data are presented as mean values ± SEM. n= 3,
**P < 0.01 and ***P < 0.001 (two-tailed unpaired t test). P values are 2.0 × 10−5 for Cnot1, 3.8 × 10−4 for Cnot2, 3.2 × 10−3 for Cnot3, 2.1 × 10−5 for Cnot6,
2.4 × 10−4 Cnot7, and 8.4 × 10−5 for Cnot8. b Immunoblot analysis of subunits of the CCR4–NOT complex in thymocyte subsets. GAPDH serves as a
loading control. Data represent three independent experiments. c Staining of CD4 and CD8 on Cnot3+/+ and Cnot3+/− thymocytes and cellularity of
thymocytes. Numbers in or adjacent to outlined areas indicate percent cells in each. Data presented were derived from five mice. Data are presented as
mean values ± SEM. NS, not significant; **P < 0.01 and ***P < 0.001 (two-tailed unpaired t test). P values are 1.0 × 10−4 for CD4 and 0.010 for CD8.
d Immunoblot analysis of subunits of the CCR4–NOT complex in DP thymocytes of Cnot3f/f Cd4-Cre and control Cnot3f/f mice. e Staining of CD4 and CD8
on Cnot3f/f Cd4-Cre and Cnot3f/f thymocytes and cellularity of thymocytes. Numbers in or adjacent to outlined areas indicate percent cells in each. Data
presented were derived from five mice. Data are presented as mean values ± SEM. NS, not significant; ***P < 0.001 (two-tailed unpaired t test). P values are
3.2 × 10−4 for CD4 and 6.9 × 10−4 for CD8.
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We next investigated regulatory roles for the CCR4–NOT
complex in the development of these thymocyte populations.
Numbers of immature CD3loCD69lo cells (population 1; mostly
DN and pre-selection DP thymocytes) and CD3intCD69lo cells
(population 2; mostly pre-selection DP cells) did not change as a
result of CNOT3 deletion. However, numbers of CD3intCD69hi
cells (population 3), CD3hiCD69hi cells (population 4; post-
positive selection thymocytes), and CD3hiCD69lo cells (popula-
tion 5; mature SP cells) were significantly reduced (Fig. 2b). Thus,
the CCR4–NOT complex is required for efficient transition of
CD3intCD69lo to later stages during positive selection of DP
thymocytes.
To confirm the role of CNOT3 in positive selection of DP
thymocytes, we further analyzed the effect of CNOT3 deficiency
on thymocyte development in mice expressing the MHC class II-
restricted OT-II T cell antigen receptor (TCR) transgene or the
MHC class I-restricted H-Y or OT-I TCR transgene. Cnot3f/f
Cd4-Cre OT-II and female H-Y or Cnot3f/f Cd4-Cre OT-I mice
had significantly fewer CD4SP and CD8SP thymocytes selected
by each antigen peptide–MHC complex than did their TCR-
transgenic Cnot3f/f littermates (Fig. 2c–e). Overall, these data
suggest that the CCR4–NOT complex promotes positive selection
in DP thymocytes.
As expected, the number of splenic T cells decreased as a result
of CNOT3-deletion (Supplementary Fig. 2a–c). The percentage of
CD44hiCD62Llo among CD4 and CD8 T cells increased as a
result of CNOT3 deletion (Supplementary Fig. 2a), implying a
homeostatic expansion of peripheral T cells due to the reduced T
cell populations in these mutant mice.
CNOT3 regulates TCR signal-inducing apoptosis of DP thy-
mocytes. We next addressed whether CNOT3 is involved in TCR
signaling-mediated positive selection of DP thymocytes. Follow-
ing initiation of positive selection, DP thymocytes normally
downregulate their expression of CD4 and CD8, passing through
a CD4+CD8int transitional stage before committing to either the
CD4+ or the CD8+ lineage37–39. We performed an in vitro two-
stage differentiation assay40. In this assay, stimulation by a
combination of TCRβ and CD2 antibodies (stimulatory culture)
and subsequent recovery from antibody engagement (recovery
culture) leads to conversion of DP thymocytes to CD4+CD8int
thymocytes. Our data showed that the number of CD4+CD8int
thymocytes was significantly reduced in the recovery culture of
DP thymocytes sorted from Cnot3f/f Cd4-Cre mice (Cnot3–/– DP
thymocytes) (Fig. 3a). Thus, CNOT3 is required for efficient
conversion of DP thymocytes to CD4+CD8int thymocytes.
Interestingly, the number of dead cells significantly increased
as a result of adding TCRβ and CD2 antibodies to the stimulatory
culture of Cnot3–/– DP thymocytes (Fig. 3b and Supplementary
Fig. 3a). Notably, in the absence of TCR stimulation, the
abundance of live cells was not significantly changed by CNOT3
deletion. This suggests that CNOT3 deletion increased TCR
signaling-mediated cell death of DP thymocytes, whereas
homeostatic survival of DP thymocytes was not affected by
CNOT3 deletion. Consistently, staining with Annexin V revealed
that Cnot3–/– DP thymocytes were more sensitive to apoptosis
induction upon stimulation with a combination of CD3 and
CD28, or a combination of TCRβ and CD2, compared to control
thymocytes (Fig. 3c and Supplementary Fig. 3a). Moreover,
in vivo injection of an anti-CD3 antibody decreased the number
of DP thymocytes more efficiently in Cnot3f/f Cd4-Cre mice than
in control mice (Fig. 3d). In contrast, the absence of CNOT3 did
not appreciably influence the cell cycle of DP thymocytes
(Supplementary Fig. 3b). Consequently, these data imply that
CNOT3 of the CCR4–NOT complex attenuates TCR-mediated
apoptosis of DP thymocytes during positive selection.
TCR signaling regulates positive selection via MAPK activa-
tion41. Moreover, JNK and p38 pathways are involved in cell
death induced by TCR signaling42. We then tested whether
CNOT3 deletion affects these intracellular signaling pathways
involving downstream TCR signaling in DP thymocytes. DP
thymocytes sorted from Cnot3f/f Cd4-Cre and control mice were
stimulated with a combination of anti-CD3ε and anti-CD4
antibodies. Phosphorylation of Jnk and p38 induced by ligand
stimulation was prolonged in Cnot3–/– DP thymocytes, compared
with control DP thymocytes (Fig. 3e). In contrast, phosphoryla-
tion of Lck, Zap70, PLCγ1, and Erk1/2 was almost identical
between Cnot3–/– and control DP thymocytes (Supplementary
Fig. 3c). Thus, it is likely that the CCR4–NOT complex influences
TCR signaling during positive selection.
CNOT3 inhibits aberrant expression of pro-apoptotic Bbc3.
We next sought to identify the target molecules by which the
CCR4–NOT complex controls TCR-mediated apoptosis of DP
thymocytes. Mass spectrometry suggested no global change of
highly expressed proteins in Cnot3f/f Cd4-Cre DP thymocytes
(Supplementary Fig. 4a). Moreover, polysome structure was
almost intact in Cnot3f/f Cd4-Cre DP thymocytes (Supplementary
Fig. 4b). These data imply that CNOT3 deletion did not cause
global change of translation in DP thymocytes. Therefore, more
comprehensive deep sequencing analysis of mRNA (RNA-seq)
was performed to determine gene expression changes in
Fig. 2 In the absence of CNOT3, differentiation of DP thymocytes is blocked during positive selection. a qPCR analysis of subunits of the CCR4–NOT
complex in DP thymocyte subsets sorted by flow cytometry. Results are presented relative to Gapdh expression. Data are presented as mean values ± SEM.
n= 3, **P < 0.01 and ***P < 0.001 (two-tailed unpaired t test). P values are 5.5 × 10−4 for Cnot1, 1.1 × 10−3 for Cnot2, 3.5 × 10−4 for Cnot3, 1.9 × 10−3 for
Cnot6, 2.2 × 10−3 for Cnot7 and 2.4 × 10−3 for Cnot8. b Surface staining of CD3 and CD69 of total thymocytes from Cnot3f/f and Cnot3f/f Cd4-Cre mice
(left). Numbers in outlined areas (left) indicate subpopulations gated at the right, and numbers in parentheses above the right-hand plots indicate
percent thymocytes in each subpopulation. Numbers adjacent to outlined areas (right) indicate percent cells in each. Below, average number of each
subpopulation. Data presented are derived from five mice. Data are presented as mean values ± SEM. *P < 0.05, **P < 0.01 and ***P < 0.001 (two-tailed
unpaired t test). P values 0.022 for Population 3, 3.9 × 10−4 for Population 4, and 2.2 × 10−3 for Population 5. c Flow cytometry of thymocytes from Cnot3f/f
or Cnot3f/f Cd4-Cre mice expressing a transgene encoding the MHC class II-restricted OT-II TCR. Top row, staining of CD4 and CD8 of total thymocytes.
Numbers in or adjacent to outlined areas indicate the percentage of cells in each. Middle row, staining with antibody to the OT-II-specific variable region
Vα2. Numbers above the bracketed lines indicate percent Vα2+ cells. Bottom row, quantification of DP thymocytes or CD4SP cells. Data are presented as
mean values ± SEM. ***P= 1.3 × 10−5 (two-tailed unpaired t test). N= 3. d Flow cytometry of thymocytes from Cnot3f/f or Cnot3f/f Cd4-Cre mice expressing
a transgene encoding MHC class I-restricted H-Y TCR. Middle row, staining with antibody to the H-Y-specific antibody T3.70. Bottom row, quantification of
DP thymocytes or CD8SP cells. Data are presented as mean values ± SEM. **P= 8.5 × 10−3 (two-tailed unpaired t test). N= 4 for Cnot3f/f HY or N= 3 for
Cnot3f/f Cd4-Cre HY. e Flow cytometry of thymocytes from Cnot3f/f or Cnot3f/f Cd4-Cre mice expressing a transgene encoding OT-I TCR. Bottom row,
quantification of DP thymocytes or CD8SP cells. Data are presented as mean values ± SEM. **P= 1.9 × 10−3 (two-tailed unpaired t test). N= 5 for Cnot3f/f
OT-I or N= 3 for Cnot3f/f Cd4-Cre OT-I.
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Fig. 3 CNOT3 is required to generate CD4+CD8int thymocytes. a Staining of CD4 and CD8 on control and Cnot3–/– DP thymocytes, left unstimulated
(medium only; left) or stimulated overnight with anti-TCRβ and anti-CD2 and analyzed immediately (middle) or washed and incubated for an additional
20 h in medium without stimulation (right). Numbers in quadrants indicate percent cells in each. Data presented were derived from four mice. b DP
thymocytes sorted by flow cytometry were stimulated with anti-TCRβ and anti-CD2 for 20 h. The percentage of dead DP thymocytes was determined
using 7AAD staining. Data are presented as mean values ± SEM. N= 5, *P= 0.022 (two-tailed unpaired t test). c DP thymocytes stimulated with plate-
bound anti-CD3ε/anti-CD28 (left, N= 4) or anti-TCRβ/anti-CD2 (right, N= 3) for 20 h. Percent live DP determined with Annexin V and 7AAD. Data are
presented as mean values ± SEM. P values of two-way ANOVA (Cnot3fl/fl vs Cnot3fl/flCd4-Cre) are 0.0001 for anti-CD3ε/anti-CD28 and below 0.0001 for
anti-TCRβ/anti-CD2 stimulation. *P < 0.05 and **P < 0.01 (two-tailed unpaired t test). P values of two-tailed unpaired t test are 0.042 for 2.5 μg/ml of anti-
CD3ε, 0.015 for 5 μg/ml of anti-CD3ε, 0.032 for 1 μg/ml of anti- TCRβ, 0.013 for 2.5 μg/ml of anti- TCRβ, 8.1 × 10−3 for 5 μg/ml of anti- TCRβ, and 3.0 × 10−3
for 10 μg/ml of anti- TCRβ stimulation. d Reduction of DP cells from Cnot3f/f or Cnot3f/f Cd4-Cre mice receiving anti-CD3ε antibody injection. Numbers of DP
cells in thymus glands of mice 32 h after the injection are shown. Data are presented as mean values ± SEM. N= 3, *P=0.034 (two-tailed unpaired t test).
e Immunoblot analysis of total and phosphorylated (p-) Jnk and p38 in extracts of sorted Cnot3f/f and Cnot3f/f. Cd4-Cre DP thymocytes unstimulated (0) or
stimulated for the indicated times with anti-CD3 and anti-CD4 antibodies. GAPDH serves as a loading control. Fold changes in band intensities normalized
against GAPDH, compared to controls (0min) are summarized in right-hand figures. Data are presented as mean values ± SEM. N= 3 for pJNK and N= 2 for
pp38. P values of two-way ANOVA (Cnot3fl/fl vs Cnot3fl/flCd4-Cre) are shown in the graph.
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populations 2, 3, and 4 of Cnot3f/f Cd4-Cremice. CNOT3 deletion
increased expression of 94 genes in population 2. Moreover, 242
and 233 genes were up-regulated in populations 3 and 4,
respectively, in the absence of CNOT3 (Fig. 4a). As expected,
gene ontology analysis indicated that pro-apoptotic genes were
significantly enriched in the up-regulated gene set by CNOT3
deletion during positive selection (Fig. 4b). Thus, these data are
consistent with the finding that CNOT3-deficient DP thymocytes
were susceptible to apoptosis during positive selection.
Among pro-apoptotic molecules commonly up-regulated in
these three populations of CNOT3-deficient thymocytes (Fig. 4c),
we focused on BCL2 binding component 3 (Bbc3) (Fig. 5a)
because Bbc3, a BH3-only protein, is reportedly involved in
thymic deletion of self-reactive T cells12. Flow cytometric analysis
suggested that the expression level of Bbc3 protein in control
thymocytes slightly increased from population 3 to 4 (Fig. 5b).
Notably, deletion of CNOT3 largely enhanced Bbc3 protein
expression in populations 4 and 5 (Fig. 5b). Thus, the
CCR4–NOT complex inhibits up-regulation of Bbc3 during
positive selection.
Poly-A tail length of Bbc3 mRNA was greater in CNOT3-
deficient thymocytes of populations 3 and 4 (Fig. 5c) whereas a
change in poly-A tail length of control mRNA was minimum in
CNOT3-deficient thymocytes (Supplementary Fig. 5a). Thus,
CCR-NOT4 shortens poly-A tails of Bbc3 mRNA in thymocytes.
Although Bbc3 mRNA is reportedly up-regulated by p53, up-
regulation of p53 mRNA by deletion of CNOT3 was minimum
(Supplementary Fig. 5b), suggesting a minor contribution of the
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Fig. 4 CNOT3 deletion up-regulates pro-apoptotic genes during positive selection. a Scatter plot of genes expressed in Cnot3f/f and Cnot3f/f Cd4-Cre
thymocytes during positive selection. Red dots indicate significantly up or down-regulated genes (2-fold change, FDR P < 0.05). b Gene ontology analysis
of genes significantly up-regulated in Cnot3f/f or Cnot3f/f Cd4-Cre thymocytes during positive selection. c Heat map (Z-scored expression) of pro-apoptotic
genes up-regulated in positive selection.
NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-020-19975-4 ARTICLE
NATURE COMMUNICATIONS |         (2020) 11:6169 | https://doi.org/10.1038/s41467-020-19975-4 |www.nature.com/naturecommunications 7
p53-dependent mechanism. A previous study showed that
deletion of CNOT3 in cardiomyocytes caused up-regulation of
Atg7, thereby inducing Bbc3 expression43. However, because
Atg7 expression was not significantly changed (Supplementary
Fig. 5b), the Atg7-dependent mechanism probably does not occur
in Cnot3–/– thymocytes. Overall, these data suggest direct
regulation of Bbc3 expression by the CCR4–NOT complex.
Bbc3 induces apoptosis by competing with anti-apoptotic
proteins, Bcl-2 and Bcl-xL, in binding pro-apoptotic molecules,
Bax and Bim6. To address the involvement of Bbc3-Bax and the
Bim axis in apoptosis induced by CNOT3 deletion, the
competitor, Bcl2, was over-expressed in Cnot3-deficient thymo-
cytes. Cnot3f/f Cd4-Cre bone marrow stem cells were transduced
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Fig. 5 Deletion of CNOT3 causes up-regulation of Bbc3 in the later stage of positive selection. a Expression level of Bbc3 in thymocytes (populations 2,
3, and 4) from Cnot3f/f and Cnot3f/f Cd4-Cre mice. Normalized expression, determined from RNA-seq data, was exhibited. Two-sided *** P < 0.001, False
Discovery rate with adjustments for multiple comparisons. N= 3 biologically independent samples. P values are 8.0 × 10−4 for Population 2, 4.0 × 10−9 for
Population 3, 6.4 × 10−17 for Population 4. b Flow cytometric analysis of Bbc3 protein during apoptosis. Cnot3f/f Cd4-Cre (red line) and Cnot3f/f (black dot)
thymocytes in each population during positive selection were stained with anti-Bbc3 antibody. N= 4 for Cnot3f/f Cd4-Cre thymocytes, and N= 3 for
Cnot3f/f thymocytes. *P= 0.030 and ***P= 3.1 × 10−4 (two-tailed unpaired t test). c Poly(A) tail PCR analysis (upper panel) for Bbc3mRNA in thymocytes
(populations 3 and 4) from Cnot3f/f (left 2 lanes) and Cnot3f/f Cd4-Cre (right 2 lanes) mice. Lower panel shows the specific PCR for Bbc3 mRNA. Two
biologically independent samples are shown. Data are typical examples of two repeated experiments. Relative intensity of the signal is plotted against the
length of the poly(A) tail PCR product determined by size markers (right figure). Black and red lines indicate the relative intensities of the poly (A) tail PCR
products from Cnot3f/f (left 2 lanes) and Cnot3f/f Cd4-Cre (right 2 lanes) thymocytes, respectively. d Flow cytometric analysis of Cnot3f/f Cd4-Cre
thymocytes transduced with control (left) and the Bcl-2 gene (right). Profiles were gated on GFP-positive cells. Data are summarized in the right-hand
figure. N= 3. *P= 0.038 (two-tailed unpaired t test). e Expression of Dab2ip in thymocytes (populations 2, 3, and 4) from Cnot3f/f and Cnot3f/f Cd4-Cre
mice. Normalized expression, determined from RNA-seq data, was exhibited. Two-sided *** P < 0.001, False Discovery rate with adjustments for multiple
comparisons. N= 3 biologically independent samples. P values are 1.2 × 10−8 for Population 2, 7.3 × 10−9 for Population 3, 5.7 × 10−8 for Population 4.
f Poly(A) tail PCR analysis (upper panel) for Dab2ip mRNA in thymocytes (populations 3 and 4) from Cnot3f/f (left 2 lanes) and Cnot3f/f Cd4-Cre (right 2
lanes) mice. Lower panel shows the specific PCR for Dab2ip mRNA. Two biologically independent samples are shown. Data are typical examples of two
repeated experiments. Relative intensity of the signal is plotted against length of poly(A) tail PCR product determined by size markers (right figure). Black
and red lines indicate the relative intensities of the poly (A) tail PCR products from Cnot3f/f (left 2 lanes) and Cnot3f/f Cd4-Cre (right 2 lanes) thymocytes,
respectively.
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transplanted into irradiated RAG-deficient mice. Positive selec-
tion impaired by CNOT3 deletion was significantly rescued by
introduction of Bcl-2 (Fig. 5d). Thus, these data suggest that
increased Bbc3 expression contributes to inappropriate apoptosis
caused by CNOT3 deletion during positive selection.
Despite Bbc3 protein up-regulation in populations 4 and 5, the
defect in positive selection started in population 3 (Fig. 2b).
Moreover, flow cytometric analysis of thymocytes showed that
phosphorylation of Jnk and p38 was slightly enhanced by CNOT3
deletion (Supplementary Fig. 6). Therefore, it is possible that
another mechanism might be involved in apoptosis induction by
CNOT3 deletion. Among the pro-apoptotic molecules up-
regulated in CNOT3-deficient thymocytes (Fig. 4c), expression
of Dab2ip increased commencing in populations 2 and 3, and was
subsequently down-regulated in population 4 (Fig. 5e). Impor-
tantly, in the absence of CNOT3, Dab2ip expression increased
significantly in populations 2 and 3 (Figs. 4c and 5e).
Consistently, polyA tails of Dab2ip mRNA were elongated by
deletion of CNOT3 in populations 3 and 4 (Fig. 5f). Given that
expression of Dab2ip promotes apoptosis44–47, impaired positive
selection in population 3 of CNOT3-deficient thymocytes could
be due to up-regulation of Dab2ip by defective functioning of the
CCR4–NOT complex.
Discussion
Thymocyte death may occur at any of three stages: if TCR beta
selection fails, if positive selection does not occur, or in the event
of thymic negative selection of self-reactive T cells. Importantly,
each process apparently employs different mechanisms. In thymic
negative selection, TCR signaling-dependent apoptosis of thy-
mocytes should be triggered when thymocytes receive strong
signaling from an interaction between TCR and the MHC-
peptide complex6. Previous studies suggest that pro-apoptotic
BIM and Bbc3 are responsible for apoptosis in this process10–12.
Our study suggests that deletion of CCR4–NOT induces up-
regulation of Bbc3 in DP thymocytes after a relatively weak
interaction of TCR and pMHC. Whereas weak TCR signaling
might be sufficient for up-regulating Bbc3, CCR4–NOT down-
regulates Bbc3 mRNAs by shortening their polyA tails, thereby
inhibiting inappropriate induction of apoptosis. Interestingly,
CCR4–NOT was down-regulated in CD4SP and CD8SP. This
suggests that CCR4–NOT complex-mediated suppression might
not participate in negative selection in which BIM and Bbc3
promote apoptosis of self-reactive T cells.
The mechanism of TCR signaling modulation by the
CCR4–NOT complex still remains unclear. Data show that the
CCR4–NOT complex up-regulates pro-apoptotic DAB2IP, which
modulates some intracellular signaling pathways such as the JNK
pathway44,46. Notably, activation of JNK and p38 induced by
TCR signaling is prolonged by deletion of CNOT3. Because
previous studies suggest that DAB2IP is involved in several dis-
tinct intracellular signaling types and events44–48, a detailed
mechanism linking up-regulated DAB2IP with TCR-dependent
hyperactivation of JNK and p38 in Cnot3–/– thymocytes needs to
be clarified in the future.
CNOT3 deletion reduced levels of other CCR4–NOT subunits
in thymocytes, thereby abolishing deadenylase activity of the
CCR4–NOT complex. RNA-seq analysis revealed a limited
impact of CNOT3 deletion on gene expression in thymocytes.
Thus, CCR4–NOT controls decay of target mRNAs in a
sequence-specific manner during thymic positive selection.
Sequence specificities of the CCR4–NOT complex are mainly
ascribed to its direct or indirect interaction with sequence-specific
RNA-binding proteins (RBPs) or micro RNAs (miRNAs)23.
Sequence-specific RBP binding to AU-rich elements (AREs), such
as tristetraproline, reportedly recruits the CCR4–NOT complex to
3′-UTRs of target mRNAs. Database searches49 suggested that
Dab2ip has AREs in the 3′-UTR, intimating possible involvement
of RBP-dependent regulation of deadenylation. In contrast,
because Bbc3 mRNA does not have typical AREs in its 3′UTR,
miRNAs may recruit the CCR4–NOT complex to the 3′-UTR of
Bbc3 mRNA. Several miRNAs consistently suppressed expression
of Bbc3 mRNA to promote cell survival50–52.
A recent study found that B cell-specific deletion of CNOT3
impaired early B-cell differentiation34,53. Inoue et al.34 showed
that CCR4–NOT regulates B cell differentiation by controlling Igh
rearrangement and by destabilizing p53 mRNA. Although the
mechanism by which CNOT3 controls proper Igh recombination
remains unknown, CNOT3 appears to mediate suppression of
p53 expression, which would allow pro–B cells to survive phy-
siological genomic changes required for proper recombination at
the Igh locus. Subsequently, proliferation of successfully recom-
bined cells would be facilitated. In contrast, the influence of
CNOT3 deletion on p53 mRNA expression was minimal in
thymocytes. Yang et al.53 reported that CNOT3 directly interacts
with transcription factor early B-cell factor 1 (Ebf1) to regulate its
transcriptional activity, thereby promoting early B cell differ-
entiation. However, because Ebf1 is specifically expressed in B
cells, its involvement in thymocyte development is unlikely.
Instead, as we report here, CNOT3 depletion induces inap-
propriate apoptosis of DP thymocytes by directly controlling
expression levels of Bbc3 and Dab2ip. Thus, in thymocytes,
mRNAs and proteins regulated by CCR4–NOT may be distinct
from those in B cells.
A previous study showed that deletion of CNOT3 in heart and
skeletal muscle caused cell death of cardiomyocytes43. In these
cells, the CCR4–NOT complex prevents abnormal up-regulation
of Atg7. Atg7 protein increased by CNOT3 deletion was localized
in nuclei and modulated p53 activity, inducing expression of
Bbc3. Interestingly, our data also suggested Bbc3-induced apop-
tosis of thymocytes. Notably, in contrast to cardiomyocytes,
CNOT3 deletion did not influence the expression of Atg7 in DP
thymocytes. Thus, Atg7-dependent activation of p53 is unlikely to
occur in thymocytes.
Mechanisms underlying the regulation of gene expression by
the CCR4–NOT complex seems to differ among tissues and cell
types. In addition to poly(A) shortening, transcription factor
activity and translation may be regulated by the CCR4–NOT
complex in a cell type-specific manner. Thus, other mechanisms
in addition to poly(A) tail regulation may contribute to down-
regulation of Bbc3 and Dab2ip by the CCR4–NOT complex in
thymocytes.
In summary, our studies suggest a link between poly(A) tail
shortening by CCR4–NOT and positive selection of DP thymo-
cytes. CNOT3 levels affect protein expression at the post-
transcriptional level, which is important for positive selection.
Given that the CCR4–NOT complex has regulatory roles in
various cell types, it will be important to compare and contrast
functions of this complex in each lineage.
Methods
Mice. To generate mice with a T cell-specific Cnot3 deficiency, mice with condi-
tional deletions of Cnot3 (Cnot3f/f) mice32 were crossed with Cd4-Cre mice (The
Jackson Laboratory). All mice were bred and maintained under specific pathogen-
free conditions and all experiments were performed in accordance with institu-
tional guidelines at OIST and RIKEN. Mice between 7 and 9 weeks of age were
used. Mice with transgenic expression of OT-I, OT-II, or H-Y TCR were from the
Jackson Laboratory. All mice were on a C57BL/6 background (7–9 weeks old). The
mice were housed in specific pathogen-free conditions. In vivo experiments were
conducted on sex-matched male and female mice. Both male and female mice were
used for in vitro and in vivo experiments. Housing conditions: ambient tempera-
ture at 23 ± 2 °C, humidity of 55 ± 15%, dark/light cycle of 12 h/12 h, and air
exchange rate of 10–15 times per hour.
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Antibodies. Phycoerythrin (PE)-conjugated antibody to mouse CD4 (L3T4),
allophycocyanin (APC)-conjugated antibody to mouse CD8α (53–6.7) or Vα2
(B20.1), Peridinin chlorophyll-cyanine 5.5-conjugated antibody to mouse CD3ε
(145-2C11), Brilliant Violet 421–conjugated antibody to mouse CD8α (53–6.7),
and APC-Cy7-conjugated antibody to mouse CD69 were from BioLegend. APC-
conjugated antibody to H-Y TCR (T3.70) was from eBioscience. Anti-Bbc3 anti-
body was from Anti-Erk1-Erk2 (4695), antibody to Erk1-Erk2 phosphorylated at
Thr202 and Tyr204 (9101), anti-Jnk1-Jnk2 (9252), antibody to Jnk1-Jnk2 phos-
phorylated at Thr183 and Tyr185 (4671), anti-p38 (8690), antibody to p38 phos-
phorylated at Thr180 and Tyr182 (9211), anti-Zap70 (2705), antibody to Zap70
phosphorylated at Tyr493 and Syk phosphorylated at Tyr526 (2701), anti-Lck
(2752), antibody to Src family kinases phosphorylated at Tyr416 (2101), anti-PLC-
γ1 (5690), antibody to PLC-γ1 phosphorylated at Tyr783 (14008), anti-GAPDH
(2118), CNOT2(6955), were from Cell Signaling Technology. Antibodies used in
this study were summarized in Supplementary Table 1.
Reverse transcriptase PCR assays. Total RNA was isolated with Isogen (Nippon
Gene Co., Ltd.). cDNA was synthesized from 0.5 to 1 µg of total RNA with Prime
Script II (Takara Bio). Quantitative RT-PCR analyses were performed on a Life
Technologies 7300 Fast Real-Time PCR System using FastStart Universal SYBR
Green Master Mix (Takara). The level of Gapdh expression was used to normalize
the data. Primers used for real-time RT-PCR are described in Supplementary
Table 2.
Immunoblot analysis. Cells were lysed in lysis buffer (50 mM Tris-HCl [pH 7.5],
150 mM NaCl, 1 mM EDTA, 1% NP-40, Roche complete protease inhibitor
cocktail). Protein concentrations were measured using the Bio-Rad protein assay.
Cell lysates were separated by SDS polyacrylamide gel electrophoresis (SDS-PAGE)
and transferred to polyvinylidene difluoride (PVDF) membranes (Immobilon P,
Merck Millipore). Membranes were then incubated with primary antibodies.
Immunoreactive proteins were visualized with anti-rabbit or anti-mouse IgG
conjugated to horseradish peroxidase (GE Healthcare), which was followed by
processing with an ECL detection system (GE Healthcare). Intensities of bands
were quantified using ImageLab software (BioRad).
In vitro assay of DP to CD4+CD8int development. Purified DP thymocytes were
resuspended in RPMI-1640 medium and incubated overnight with plate-bound
anti-TCRβ (H57; BioLegend) and anti-CD2 (RM2-5; BioLegend)34. Cells were
washed extensively and analyzed immediately by flow cytometry (stimulatory
culture) or incubated for an additional 20 h in the same medium without stimu-
lation before analysis (recovery culture). In selected experiments, cells were incu-
bated with SP600125 (10 µM) (Sigma), or SB203580 (1 µM) (Millipore).
Generation of bone marrow chimeras. Bone marrow cells collected from con-
genic C57BL/6 (CD45.1+) mice were mixed at a ratio of 1:1 with bone marrow cells
from Cnot3f/f or Cnot3f/f Cd4-Cre (CD45.2+) mice and the mixture (5 × 106) was
injected into tail veins of irradiated Rag1−/− mice (600 rads). Mice were analyzed
7–8 weeks after bone marrow transfer.
Retroviral transduction of lineage-negative cells. cDNAs encoding Bcl-2 were
inserted into a mouse stem cell virus (MSCV)-based retroviral vector and an
internal ribosome entry site (IRES)-green fluorescent protein (GFP) cassette
(Addgene). Retroviral vectors were transfected into the packaging Plat-E cells
together with the retroviral packaging vector pCL-Eco (addgene) using Lipo-
fectamine 2000 and Opti-MEM I reagents (Invitrogen). 48 h after transfection, the
supernatant was harvested, centrifuged, and filtered (0.45 μm) prior to immediate
use for spin-infection. On day 3, another harvest was performed. Bone marrow
cells from Cnot3f/f or Cnot3f/f Cd4-Cre mice were recovered from femurs and tibias
of 6–12-week old mice. After red cell lysis, cells were enriched in Lin− cells using
the mouse Lineage Cell Depletion kit and LS MACS columns (Miltenyi Biotec).
Lin− bone marrow cells were then cultured at 106/well in 24-well plates in RPMI-
1640 medium supplemented with 20% FCS and recombinant murine cytokines,
interleukin (IL)-3 (10 ng/mL), IL-6 (20 ng/mL) and stem cell factor (SCF) (40 ng/
mL) (PeproTech). The next day (day1), the media was replaced with filtered, fresh
retrovirus-containing supernatant supplemented with 6 μg/mL polybrene (Hex-
adimethrine bromide, Sigma) and cytokines, as indicated above, prior to cen-
trifugation for 1 h at 1300 G at 32 °C. After 3 h of incubation at 37 °C in a 5% CO2
incubator, the supernatant was replaced with complete fresh media. Another
transduction was performed on day 2. On day 3, non-adherent cells were har-
vested, counted, analyzed for GFP fluorescence on a flow cytometer, and injected
into tail veins of irradiated Rag1−/− mice (600 rads).
Detection of phosphorylated p38 and Jnk. Thymocytes were stained with Bril-
liant Violet 421-conjugated antibody to mouse CD3 and FITC conjugated anti-
CD69 before fixation (BD Cytofix) for 30 min on ice. Cells were washed and
permeabilized with BD Perm I buffer for 10 min on ice. Cells were washed and
stained with anti-phospho-p38-PE (BD; 612565) or anti-phospho-Jnk-Alexa Fluor
647 (Cell Signaling Technology; 9257) at room temperature for 60 min. Flow
cytometry was performed using FACA Aria III (BD).
TCR stimulation-induced cell death assay. Double-positive thymocytes were
isolated by positive selection of total thymocytes with anti-CD8α magnetic beads
(Miltenyi Biotech), with resulting purity >90%. For plate-bound CD3/28 or TCRβ/
CD2 stimulation, plates were coated overnight with indicated concentrations of
antibodies at 4 °C. In vitro death assays were performed in triplicate in 24-well, flat-
bottom plates with 2 × 106 cells per well for 20 h. The percentage of live DP
thymocytes was determined with annexin V staining.
Poly(A) tail length assay. Poly(A) tail length was determined using a USB Poly
(A) Tail-Length Assay (Affymetrix, Inc.). Briefly, poly(A) polymerase adds a lim-
ited number of guanosine and inosine residues to the 3′-ends of poly(A)-containing
RNAs. Tailed-RNAs were converted to cDNA through reverse transcription using
the newly added G/I tails as priming sites. Gene-specific forward primers (Sup-
plementary Table 2) and the universal reverse primer provided with the kit were
used to generate a product that includes poly(A) tails of the gene of interest. PCR
products were separated on 2% agarose gels, stained with ethidium bromide,
visualized with an ImageQuant LAS 4000 (GE Healthcare), and analyzed by
Image J.
Polysome fraction assay. Translation efficiency of mRNA was monitored based
on the relative distribution of mRNA in polysome fractions. Thymocytes were
washed twice with cold PBS and suspended for 15 min in 500 μL of lysis buffer
(10 mM HEPES-KOH (pH 7.4), 10 mM MgCl2, 150 mM KCl, 100 μg/mL cyclo-
hexamide, 40 U/mL RNaseOUT (Invitrogen), 1 mM dithiothreitol, 2% NP40,
and 10 mM PMSF). Lysates were centrifuged at 16,000 g for 10 min at 4 °C and
supernatants were subjected to a 10–50% sucrose density gradient prepared in
20 mM HEPES-KOH (pH 7.4), 100 mM KCl and 5 mMMgCl2, which was followed
by centrifugation at 40,000 r.p.m. for 2 h at 4 °C with an SW41 Ti rotor on an
Optima LE-80K ultracentrifuge (Beckman Coulter). The gradient was then frac-
tionated using a Gradient Station (BioComp) with simultaneous monitoring of the
absorbance at 254 nm (UV monitor: Bio-Rad EM-1). RNA from each fraction was
isolated with Isogen LS (Nippon Gene Co., Ltd.)
Liquid chromatography-mass spectrometry. Each sample was reduced with
100mM dithiothreitol at 56 °C for 30min, and then alkylated with 550mM
iodoacetamide for 30min in the dark. Samples were washed with 50 mM ammo-
nium bicarbonate using PALL NanoSep 10-KDa spin filters. After washing, samples
were digested with trypsin overnight at 37 °C. Peptides were released from the filter
using 1% formic acid and 20% acetonitrile in water. After extraction, peptides were
concentrated with a centrifugal vacuum concentrator and then resuspended in 0.1%
formic acid in water. All samples were analyzed using a Thermo Scientific Q-
Exactive Plus Orbitrap hybrid mass spectrometer (Thermo Fisher Scientific, Wal-
tham, MA, USA). The mass spectrometer was equipped with an HPLC (Dionex
Ultimate 3000 nanoRSLC), an autosampler (HTC PAL, CTC Analytics), and a
nanoelectrospray ion source. 5-μL samples were separated on a Zorbax 300SB C18
column (0.3 × 150mm; Agilent, Agilent Technologies, Waldbronn, Germany) at
40 °C. A one-hour gradient was employed. Solvent A was distilled water with 0.1%
formic acid, and solvent B was acetonitrile with 0.1% formic acid. A flow rate of
3.5 μL/min was used for peptide separation. The temperature of the heated capillary
was 300 °C, and a 1.9-kV spray voltage was applied to all samples. Acquired MS/MS
data were analyzed on Mascot (version 2.4, Thermo Fisher Scientific, Waltham, MA,
USA) and Proteome Discoverer (version 1.4, using Sequest HT, Thermo Fisher
Scientific, Waltham, MA, USA). The Uniprot proteome database for Mus musculus
(UP000000589), merged with the common Repository of Adventitious Proteins
database (cRAP; http://www.thegpm.org/crap/) was used for protein identification,
using a False Discovery Rate of <1% as a cutoff threshold, determined with the
Percolator algorithm in Proteome Discoverer software.
RNA-seq analysis. Populations 2, 3, and 4 were sorted using an Aria II. Total
RNA was extracted from sorted thymocytes with TRIzol reagent according to the
manufacturer’s protocol (Thermo Fisher Scientific, Waltham, MA). The RNA-Seq
library was constructed using an NEBNext Ultra Directional RNA Library Prep Kit
(New England Biolabs [NEB], Ipswich, MA) after depleting rRNA with an NEB-
Next rRNA Depletion Kit (NEB). Paired-end sequencing (2 × 36 bases) was per-
formed. Sequence reads were mapped using CLC Genomics Workbench (Version
11.0.1; Qiagen, Redwood City, CA). Differential expression was determined by
empirical analysis using the Empirical Analysis of DGE tool (edgeR test) in CLC
Genomics Workbench and CLC Main Workbench.
Statistical analysis. Statistically significant differences between mean values were
determined using Student’s t test (***P < 0.001, **P < 0.01 and * P < 0.05). Values
represent means of samples ± SEM. Prior experience and pilot studies were used
for estimation of sample size to ensure adequate power. No data points or mice
were excluded from the study. No randomization or blinding was used.
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Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.
Data availability
Data that support the findings of this study have been deposited in DDBJ with the
accession codes DRA009481 (and ftp://ftp.ddbj.nig.ac.jp/ddbj_database/dra/fastq/
DRA009/DRA009481). The source data underlying all figures and supplementary figures
are provided as a Source Data file. Source data are provided with this paper.
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